ENBIFELIX

Serial Number 88258688
Registration 6669198
700

Registration Progress

Application Filed
Jan 11, 2019
Under Examination
Approved for Publication
Dec 28, 2021
Published for Opposition
Dec 28, 2021
Registered
Mar 15, 2022

Trademark Image

ENBIFELIX

Basic Information

Serial Number
88258688
Registration Number
6669198
Filing Date
January 11, 2019
Registration Date
March 15, 2022
Published for Opposition
December 28, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 15, 2022
Registration
Registered
Classes
005

Rights Holder

Samsung Bioepis Co., Ltd.

99
Address
107, Cheomdan-daero, Yeonsu-gu,
Incheon 21987
KR

Ownership History

Samsung Bioepis Co., Ltd.

Original Applicant
99
Incheon KR

Samsung Bioepis Co., Ltd.

Owner at Publication
99
Incheon KR

Samsung Bioepis Co., Ltd.

Original Registrant
99
Incheon KR

Legal Representation

Attorney
Stephen R. Barrese, Esq.

USPTO Deadlines

Next Deadline
792 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220315)
Due Date
March 15, 2028
Grace Period Ends
September 15, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Mar 15, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 28, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 28, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 8, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 22, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 25, 2021 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Oct 15, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 13, 2021 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Mar 25, 2021 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Mar 8, 2021 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jul 15, 2020 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Jan 14, 2020 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Jul 11, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 11, 2019 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jul 11, 2019 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 6, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 6, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 6, 2019 ALIE A ASSIGNED TO LIE Loading...
Jul 1, 2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Mar 28, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Mar 28, 2019 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Mar 28, 2019 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 26, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 2, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 15, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis

Classification

International Classes
005